92 related articles for article (PubMed ID: 21054985)
41. Molecular mechanism of Poria cocos combined with oxaliplatin on the inhibition of epithelial-mesenchymal transition in gastric cancer cells.
Wang N; Liu D; Guo J; Sun Y; Guo T; Zhu X
Biomed Pharmacother; 2018 Jun; 102():865-873. PubMed ID: 29710543
[TBL] [Abstract][Full Text] [Related]
42. Prospective, randomized trial comparing 5-FU/LV with or without oxaliplatin as adjuvant treatment following curative resection of gastric adenocarcinoma.
Zhang XL; Shi HJ; Cui SZ; Tang YQ; Ba MC
Eur J Surg Oncol; 2011 Jun; 37(6):466-72. PubMed ID: 21414740
[TBL] [Abstract][Full Text] [Related]
43. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
[TBL] [Abstract][Full Text] [Related]
44. Induction of metastasis by S100P in a rat mammary model and its association with poor survival of breast cancer patients.
Wang G; Platt-Higgins A; Carroll J; de Silva Rudland S; Winstanley J; Barraclough R; Rudland PS
Cancer Res; 2006 Jan; 66(2):1199-207. PubMed ID: 16424059
[TBL] [Abstract][Full Text] [Related]
45. Low-dose oxaliplatin enhances the antitumor efficacy of paclitaxel in human gastric cancer cell lines.
Gu J; Yamamoto H; Lu X; Ngan CY; Tsujino T; Konishi K; Takemasa I; Ikeda M; Nagata H; Hashimoto S; Matsuzaki T; Sekimoto M; Takagi A; Monden M
Digestion; 2006; 74(1):19-27. PubMed ID: 16988507
[TBL] [Abstract][Full Text] [Related]
46. LASP-1 induces proliferation, metastasis and cell cycle arrest at the G2/M phase in gallbladder cancer by down-regulating S100P via the PI3K/AKT pathway.
Li Z; Chen Y; Wang X; Zhang H; Zhang Y; Gao Y; Weng M; Wang L; Liang H; Li M; Zhang F; Zhao S; Liu S; Cao Y; Shu Y; Bao R; Zhou J; Liu X; Yan Y; Zhen L; Dong Q; Liu Y
Cancer Lett; 2016 Mar; 372(2):239-50. PubMed ID: 26797416
[TBL] [Abstract][Full Text] [Related]
47. Clinical significance of IGF1R gene expression in patients with Stage II/III gastric cancer who receive curative surgery and adjuvant chemotherapy with S-1.
Numata K; Oshima T; Sakamaki K; Yoshihara K; Aoyama T; Hayashi T; Yamada T; Sato T; Cho H; Shiozawa M; Yoshikawa T; Rino Y; Kunisaki C; Akaike M; Imada T; Masuda M
J Cancer Res Clin Oncol; 2016 Feb; 142(2):415-22. PubMed ID: 26337161
[TBL] [Abstract][Full Text] [Related]
48. [Construction of pGL3-hTERT-tk recombinant plasmid and effect of PEG-PEI/Fe(3)0(4) Nano-magnetic fluid-tk/GCV on proliferation of gastric cancer cells BGC823 in vitro].
Buduwaili WS; Li L; Zhang BC
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Jul; 15(7):727-31. PubMed ID: 22851080
[TBL] [Abstract][Full Text] [Related]
49. Proteomic biomarker predicts therapeutical effects of oxaliplatin combining with fluoropyrimidine in metastatic gastric cancer patients by the SELDI-proteinchip platform.
Yu Z; Yu JK; Fang XF; Yuan Y; Shen H
Hepatogastroenterology; 2013 Oct; 60(127):1800-4. PubMed ID: 24624447
[TBL] [Abstract][Full Text] [Related]
50. S100P as a marker for poor survival and advanced stage in gallbladder carcinoma.
Mathai AM; Alexander J; Huang HY; Li CF; Jeng YM; Fung KM; Harris WP; Swanson PE; Truong C; Yeh MM
Ann Diagn Pathol; 2021 Jun; 52():151736. PubMed ID: 33798925
[TBL] [Abstract][Full Text] [Related]
51. Induction of pancreatic cancer cell apoptosis, invasion, migration, and enhancement of chemotherapy sensitivity of gemcitabine, 5-FU, and oxaliplatin by hnRNP A2/B1 siRNA.
Gu WJ; Liu HL
Anticancer Drugs; 2013 Jul; 24(6):566-76. PubMed ID: 23525071
[TBL] [Abstract][Full Text] [Related]
52. Overexpression of S100P promotes colorectal cancer metastasis and decreases chemosensitivity to 5-FU in vitro.
Dong L; Wang F; Yin X; Chen L; Li G; Lin F; Ni W; Wu J; Jin R; Jiang L
Mol Cell Biochem; 2014 Apr; 389(1-2):257-64. PubMed ID: 24381058
[TBL] [Abstract][Full Text] [Related]
53. [Down-regulation of caveolin-1 in gastric carcinoma and its clinical biological significance].
Gao X; Sun Y; Huang L; Chen XY; Zhang KL; Kong QY; Liu J; Li H
Ai Zheng; 2005 Mar; 24(3):311-6. PubMed ID: 15757532
[TBL] [Abstract][Full Text] [Related]
54. [Knock-down of ZEB1 inhibits the proliferation, invasion and migration of gastric cancer cells].
Chen D; Chu Y; Zheng Q; Xu Z; Zhou P; Li S
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Aug; 33(8):1073-1078. PubMed ID: 28871949
[TBL] [Abstract][Full Text] [Related]
55. S100P immunostaining identifies a subset of peripheral-type intrahepatic cholangiocarcinomas with morphological and molecular features similar to those of perihilar and extrahepatic cholangiocarcinomas.
Tsai JH; Huang WC; Kuo KT; Yuan RH; Chen YL; Jeng YM
Histopathology; 2012 Dec; 61(6):1106-16. PubMed ID: 22882148
[TBL] [Abstract][Full Text] [Related]
56. S100P sensitizes ovarian cancer cells to carboplatin and paclitaxel in vitro.
Wang Q; He Z; Gao J; Hu S; Huang M; Liu M; Zheng J; Tang H
Cancer Lett; 2008 Dec; 272(2):277-84. PubMed ID: 18762368
[TBL] [Abstract][Full Text] [Related]
57. Impact of adjuvant chemotherapy in the long-term outcome of patients with resected gastric cancer.
Grau JJ; Martín M; Fuster J; Pera M; García-Valdecasas JC; Bombí JA; Bordas JM; Alcobendas F; Grande L; Estapé J
J Surg Oncol; 2003 Apr; 82(4):234-40. PubMed ID: 12672007
[TBL] [Abstract][Full Text] [Related]
58. A phase II study of docetaxel and oxaliplatin combination in recurrent gastric cancer patients after fluoropyrimidine and/or cisplatin adjuvant treatment: a Korean Cancer Study Group Protocol ST06-02.
Choi YH; Oh SC; Kim JS; Nam SH; Kim BS; Cho SH; Chung IJ; Song EK; Yim CY; Baek JH; Jeung HC; Hong YS; Yang SH; Kang HJ
Cancer Chemother Pharmacol; 2012 Nov; 70(5):665-72. PubMed ID: 22926638
[TBL] [Abstract][Full Text] [Related]
59. EBP50 gene transfection promotes 5-fluorouracil-induced apoptosis in gastric cancer cells through Bax- and Bcl-2-triggered mitochondrial pathways.
Lv XG; Ji MY; Dong WG; Lei XF; Liu M; Guo XF; Wang J; Fang C
Mol Med Rep; 2012 May; 5(5):1220-6. PubMed ID: 22366766
[TBL] [Abstract][Full Text] [Related]
60. In vitro effects of recombinant human growth hormone on growth of human gastric cancer cell line BGC823 cells.
Chen JY; Liang DM; Gan P; Zhang Y; Lin J
World J Gastroenterol; 2004 Apr; 10(8):1132-6. PubMed ID: 15069712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]